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Pixuna virus modifies host cell 
cytoskeleton to secure infection
Pedro Ignacio Gil1, Guillermo Albrieu-Llinás1, Estela Cecilia Mlewski1,4, Marina Monetti1, 
Laura Fozzatti1, Cecilia Cuffini1, José Fernández Romero2,3, Patricia Kunda1,5 & María Gabriela 
Paglini1,6
Pixuna virus (PIXV) is an enzootic member of the Venezuelan Equine Encephalitis Virus complex and 
belongs to the New World cluster of alphaviruses. Herein we explore the role of the cellular cytoskeleton 
during PIXV replication. We first identified that PIXV undergoes an eclipse phase consisting of 4 h 
followed by 20 h of an exponential phase in Vero cells. The infected cells showed morphological changes 
due to structural modifications in actin microfilaments (MFs) and microtubules (MTs). Cytoskeleton-
binding agents, that alter the architecture and dynamics of MFs and MTs, were used to study the role 
of cytoskeleton on PIXV replication. The virus production was significantly affected (p < 0.05) after 
treatment with paclitaxel or nocodazole due to changes in the MTs network. Interestingly, disassembly 
of MFs with cytochalasin D, at early stage of PIXV replication cycle, significantly increased the virus 
yields in the extracellular medium (p < 0.005). Furthermore, the stabilization of actin network with 
jasplakinolide had no effect on virus yields. Our results demonstrate that PIXV relies not only on intact 
MTs for the efficient production of virus, but also on a dynamic actin network during the early steps of 
viral replication.
Pixuna virus (PIXV) is a New World alphavirus from the family Togaviridae and belongs to the Venezuelan 
Equine Encephalitis (VEE) complex1. The VEE complex comprises 14 varieties of enzootic and epizootic viruses. 
The epizootic strains emerge periodically in regions of Central America and northern areas of South America 
(Venezuela and Colombia), causing outbreaks that involve humans and horses, with high morbidity and mortality 
rates2, 3. Mosquitoes with PIXV bite and infect birds, rodents, domestic animals and humans. Although PIXV was 
first isolated from Anopheles (Stethomyia) nimbus mosquitoes in Brazil, in 19614 and has been detected later in 
Argentina5, little is known about the mechanisms concerning the cell biology of viral infection.
Viruses use the host cell machinery for entry, replication, transport, and release of viral progeny. After bind-
ing to receptors on the plasma membrane, alphaviruses enter the host cells by clathrin-mediated endocytosis 
and fusion with endosomal membranes6. Many studies have previously demonstrated that viruses can use actin 
microfilaments (MFs) and microtubules (MTs) transport systems to accomplish several steps during their life 
cycle7–11. These steps include: (i) the transport of newly synthesized viral proteins and genomes to specific sites 
within the infected cell for virus assembly and (ii) the membrane extrusion (viral budding) that ends with the 
exit of new viral progeny from the infected cell7–11. In the cell periphery and possibly in the nucleus, transport is 
mediated by the actin system, either by newly polymerized MFs that push the virus particles, or by myosins mov-
ing alongside actin filaments. The motor proteins dynein and kinesin catalyze transport along MTs, thus bridging 
the gap between the periphery and the cell center12, 13. In a later stage, the viral glycoproteins are transported 
in vesicles on MTs from the trans Golgi network to the site of budding beneath the plasma membrane prior to 
virus egress. Although some mechanism of trafficking, implicated in the modulation of alphavirus infection, have 
been elucidated14, little is known about the participation of cytoskeleton during the replication of New World 
alphaviruses.
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In this study, we evaluated whether proper dynamics of MTs and MFs are necessary for a successful PIXV 
replication. To this end, we used chemical agents that interfere with the normal polymerization or depolymeri-
zation of MFs and MTs during different stages of PIXV replication cycle. Our results showed that infection with 
PIXV affected drastically the morphology of infected cells by altering the regular arrangement of cytoskeleton. 
Surprisingly, actin disruption during the early stage of viral replication increased significantly extracellular viral 
yields, while perturbations of MTs network strongly decreased virus production. Understanding the relationship 
of PIXV with the host cytoskeleton will provide not only a valuable insight into host cell-virus interactions, but 
may also explain the pathogenic properties of VEE viruses.
Results
The PIXV replication cycle. In order to characterize the different phases of the viral growth curve, the 
amount of infectious virus produced over time was evaluated by means of plaque assay. Vero cells were first 
infected with different multiplicity of infection (MOI = 0.1, 1, and 10) to select the proper MOI for subsequent 
experiments. After 24 h post infection (h.p.i.), monolayers infected with MOI = 0.1 showed a strong cytopathic 
effect, clearly identified under phase contrast microscope as cell rounding and cytoplasm enlargement. Moreover, 
monolayers infected with MOI = 1 and MOI = 10 showed an evident loss of confluence and severe cell damage 
(Fig. 1A). Based on these observations, the subsequent experiments were performed using MOI = 0.1. Figure 1B 
shows the duration of the different phases of PIXV growth curve. There was a lack of infectious virus in the extra-
cellular medium during the first 4 h.p.i. (eclipse phase). The maximum viral yields were observed in the expo-
nential or logarithmic phase that lasted 20 h. Finally, the infected cell monolayers reached their stationary phase, 
showing signs of lysis and cell death. The time course of PIXV infection was also studied using indirect immu-
nofluorescence (IF) and Western blot. The presence of viral proteins was first visualized by IF at 8 h.p.i. in the 
perinuclear region, and after 12 h.p.i. in a large area of the cytoplasm (Fig. 1C). Western blot analyses identified 
Figure 1. PIXV replication cycle in Vero cells. (A) PIXV induces modifications in the morphology of Vero 
cells at different MOI (0.1, 1 and 10) after 24 h of infection. Vero cells monolayer mock-infected or infected 
at MOI 0.1 (top) and MOI 1 or 10 (lower panel of the figure) were imaged with phase contrast microscopy at 
low magnification. The cytopathic effect (CPE) is observed from MOI 0.1, with the maximum disruption of 
the monolayer at MOI 10 (arrows). (B) PIXV growth curve in Vero cells. Monolayers were infected with MOI 
0.1 and culture media were collected at different times (2, 4, 6, 8, 12, 18, 24 and 48 h.p.i.) and then assayed for 
infectious viral particles using a standard plaque assay. Note that infectious virus was detected after 12 h.p.i. 
and the maximum viral release was at 24 h.p.i. (C) Distribution of PIXV structural proteins during Vero cells 
infection. Vero cells were fixed at 8, 12 and 24 h.p.i. and processed for IF microscopy using an anti-PIXV 
mouse antibody and then Alexa Fluor 488-conjugated goat anti-mouse IgG (green). Scale bar = 20 µm. (D) 
Representative immunoblot showing the expression levels of PIXV structural proteins in infected Vero cells. 
Infected cells were harvested after 4, 8, 12 and 24 h p.i. Note that anti-PIXV polyclonal antibody recognizes E2, 
E1 and C viral proteins and that the levels of these proteins increase after 8 h p.i. E1: Envelope protein 1; E2: 
Envelope protein 2; C: Capsid protein. GAPDH was used as a loading control.
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PIXV viral proteins and showed increasing levels of viral protein expression during the course of infection. The 
viral protein E1 (49kD) was detected at 8 h.p.i., and subsequently E2 (58kD) and C (30kD) (Fig. 1D).
The effects of PIXV infection on host cell cytoskeleton. We examined the impact of PIXV infection 
on the host cell cytoskeleton. For this purpose, Vero cell monolayers were fixed at 8, 12 and 24 h.p.i. and processed 
for IF. PIXV infection induced changes in MFs and MTs organization that affected the cell morphology (Fig. 2). 
At 8 h.p.i., MTs showed lost of the radial assembly from the microtubules organizing center, to distribute gradu-
ally in a concentric pattern towards the center of the cell. At 24 h.p.i. cells showed clear signs of enlargement and 
the MTs bundles were distributed in a concentric belt in the cell periphery (Fig. 2, middle panel). A similar feature 
was observed in the actin cytoskeleton, which showed an acute disruption after 8 h.p.i. MFs rearrangement was 
more evident after 12 h.p.i., and progressed over time until the actin fibers disappeared (Fig. 2, upper panel).
The role of the host cell cytoskeleton during PIXV infection. The Vero cell monolayers were exposed 
to different concentrations of drugs that cause either stabilization or destabilization of MTs and MFs. The relative 
cellular metabolic activity after 24 h exposure was evaluated using the XTT assay. The concentration (for each 
drug) that caused only a 10% reduction in metabolic activity was used in subsequent experiments (Fig. 3). Table 1 
summarizes the result of this experiment.
To determine the role of MTs on the progression of viral cycle, Vero cells were infected with PIXV and 
continuously exposed to nocodazole (NZ; (18.75 μM) or paclitaxel (TX; (31.5 μM). The virus production was 
tested at 8, 12, and 24 h.p.i. by using the plaque assays. The treatment with NZ or TX produced a significant 
decrease in viral titers at every times point tested (Fig. 4A and B). NZ induced a 6-fold reduction in virus yields 
at 8 h.p.i. [F(1,10) = 9.145; p < 0.013], 5-fold at 12 h.p.i. [F(1,10) = 29.228; p < 0.001] and 14-fold at 24 h.p.i. 
[F(1,10) = 33.400; p < 0.001] when compared to their respective virus control (Fig. 4A). Treatment with TX 
showed a stronger effect than NZ, producing a 12-fold reduction in viral release at 8 h.p.i. [F(1,10) = 122.35; 
p < 0.001], 16-fold at 12 h.p.i. [F(1,10) = 8.026; p < 0.018] and 10-fold at 24 h.p.i. [F(1,10) = 4.965; p < 0.05] 
(Fig. 4B).
These results encouraged us to explore if MTs dynamic integrity has a functional impact during the early and/
or late phases of PIXV replication. To this end, infected Vero monolayers were exposed to NZ or TX during the 
first 4 h.p.i (eclipse phase) or during the exponential growth phase, (4 to 12 h.p.i). The cell supernatants were 
harvested at 8 and 12 h.p.i. and the virus titers determined using the plaque assay. The treatment with NZ during 
the eclipse period induced a 8-fold reduction in virus yields at 8 h.p.i. [F(1,10) = 5.449; p < 0.042] and 9-fold 
at 12 h.p.i. [F(1,10) = 31.014; p < 0.001], when compared to the respective virus control (Fig. 5A). During the 
exponential phase, NZ caused a 6-fold reduction in the virus yields at 8 h.p.i. [F(1,10) = 11.667; p. < 0.001] and 
129-fold at 12 h.p.i. [F(1,10) = 20.033; p < 0.001] (Fig. 5B). In contrast, no significant differences were observed 
in the viral titers after the treatment with TX during the eclipse period (Fig. 5C). Nonetheless, the treatment with 
TX during the exponential phase induced a fall of approximately 20-fold in the amount of extracellular infectious 
virus at 8 h.p.i. [F(1,10) = 133.44; p < 0.001] and 7-fold at 12 h.p.i. [F(1,10) = 21.599; p < 0.001] (Fig. 5D).
To further investigate the role of actin cytoskeleton on PIXV replication, monolayers of infected Vero 
cells were exposed to cytochalasin D (Cyt D; 2.5 μM) or jasplakinolide (Jpk; 0.7 μM). The treatment with Cyt 
D remarkably increased virus yields at every time point tested (Fig. 4C). By 8 h.p.i., cells treated with Cyt D 
Figure 2. Time course changes in actin and tubulin cytoskeleton of PIXV-infected Vero cells. Mock-infected 
cells or cells infected with PIXV (MOI 0.1), were fixed at 8, 12 and 24 h p.i. and processed for IF. Actin and 
tubulin were visualized using phalloidin-rhodamine (red) and anti-α-tubulin antibody (green), respectively. 
Nuclei were stained with DAPI (blue). Note the progressive disorganization of cytoskeleton in infected cells 
after 8 h p.i. in comparison with control non infected cells. Scale bar: 20 µm.
www.nature.com/scientificreports/
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produced a 40-fold increase in virus yields when compared to virus control [F(1,13) = 11.507; p < 0.005], 84-fold 
at 12 h.p.i. [F(1,12) = 36316; p < 0.001] and 11-fold at 24 h.p.i. [F(15,13) = 11.161; p < 0.005] (Fig. 4C). Otherwise, 
no significant changes were detected after exposure to Jpk at any time point (Fig. 4D).
To assess if the integrity of MFs dynamic has a functional impact during early and/or late phases, infected 
Vero monolayers were exposed to Cyt D during the first 4 h.p.i (eclipse phase) or during the exponential growth 
phase (4 to 12 h.p.i). The treatment with Cyt D during the eclipse period elicited a 4-fold increase in virus yields 
when compared to the untreated infected monolayers (virus control) at 8 h.p.i. [F(1,12) = 13.350; p < 0.003] and 
3-fold at 12 h.p.i. [F(1,14) = 43.441; p < 0.001] (Fig. 5E). No significant changes in viral titers were detected after 
exposure to Cyt D during exponential phase of PIXV replication cycle (Fig. 5F).
Discussion
The main goal of this study was to evaluate the interconnection between the host cell cytoskeleton and PIXV in 
the course of viral replication. To this end, we characterized the kinetics of PIXV growth, in vitro, through differ-
ent methodologies, including plaque assay, IF microscopy and western blot. PIXV growth curve consisted in an 
eclipse phase that lasted 4 h, followed by 20 h of exponential phase during which the release of viral particles to the 
extracellular medium was accelerated. The growth curve we obtained in Vero cells is consistent with the one we 
previously described in mouse embryonic fibroblasts15. The kinetic of PIXV proteins, detected by IF and western 
blot, are also in agreement with the viral growth curve (Fig. 1).
Figure 3. Dose-response curves to NZ, TX, Cyt D, and Jpk in Vero cells. The cellular metabolic activity was 
measured in Vero cells using the XTT assay. The graphs show % of cellular metabolic activity (mean ± SEM) 
relative to cell control (triplicates per condition, three independent experiments). The vertical lines represent 
non-toxic drug concentrations (90% of metabolic activity) chosen for subsequent assays.
Target Drugs
Used Concentration 
(μM) Mode of Action
Microfilaments
Cytochalsin D 2.5 Binds to filamentous actin and disrupts polymerization32
Jasplakinolide 0.7 Binds to filamentous actin and stabilizes33
Microtubules
Nocodazole 18.75 Binds to β-tubulin and prevents interchain bonds34
Paclitaxel 31.5
Binds to assembled microtubules and 
enhances the formation of highly 
stable microtubules35
Table 1. Summary of drugs targeting the cytoskeleton and their mode of action.
www.nature.com/scientificreports/
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The strong cytopathic effect, identified under phase contrast microscope as cell rounding and cytoplasm 
enlargement, was most likely due to the noticeable reorganization of the cytoskeleton. In fact, MFs were disrupted 
in the subcortical region of infected cells, and they became more disorganized towards the end of PIXV replica-
tion cycle (Fig. 2). Additionally, MTs also lost their typical arrangement and, at 24 h.p.i., they were clearly distrib-
uted concentrically around the nucleus (Fig. 2). These observations are in agreement with previous reports that 
demonstrated that other alphavirus proteins dismantle or reorganize the MTs and MFs. In this sense, a proteomic 
analysis and functional studies have revealed that cytoskeleton proteins, including actin and tubulin, are regulated 
differentially upon Chikungunya (CHIKV) infection. Interestingly, actin was found to be down-regulated after 
infection with CHIKV in SJCRH30 rhabdomyosarcoma cells16. Moreover, an intact actin network is essential at 
the early stages of Semliki Forest virus (SFV, alphavirus) trafficking and its disruption has been observed at the 
late time-points of infection17. This indicates that MFs may play an important role mediating viral trafficking in 
the alphavirus family.
Subsequently, the possible role of the cytoskeleton during different stages of PIXV replication cycle was ana-
lyzed using drugs that alter the normal architecture and dynamics of MTs and MFs. Treatment with TX or NZ 
during the entire cycle caused a significant decrease in virus yields. This suggests that the stabilization of MTs 
and/or the inhibition of its polymerization affect the intracellular viral kinetics. The destabilization of MTs with 
NZ during the eclipse or during the exponential phase had an inhibitory effect on the release of viral particles. 
We have to consider that NZ has a reversible destabilizing effect on MTs, meaning that these structures recover 
their normal dynamics once the drug is removed. In this context, it is remarkable that an early destabilization 
of MTs, during only the first 4 hours, is sufficient to reduce the virus release at different time points after infec-
tion. Contrarily, the stabilization of MTs with TX must be sustained throughout the replication cycle to obtain a 
similar result; besides, the treatment with TX seems to have a milder effect on the release of infective particles. 
Taken together, these results suggest that intact MTs are essential for the maturation and/or trafficking processes 
of PIXV proteins to specific sites. This process is performed to achieve an effective viral assembly and budding 
of viral progeny, as supported by previous studies with other viruses8, 13, 18, 19. Frolova et al.20 observed that NZ 
significantly reduces the budding of another alphavirus, Sindbis virus (SINV). This study suggests that NZ blocks 
the release of virus particles by inhibiting cytopathic vacuoles and/or glycoprotein transport instead of interfering 
with viral RNA replication. Additionally, the movement of SFV replication complexes is not required for RNA 
replication and virus production, but MTs disruption by NZ has a negative effect on virus release17.
Figure 4. Effect of microtubule or microfilament disrupting agents on virus production during the entire viral 
cycle. Treated Vero cells (black bars) and control cells (grey bars) were infected with PIXV. Treated cells were 
exposed to NZ (A), TX (B), Cyt D (C) and Jpk (D) during the complete viral cycle. Infectious particles from the 
supernatants were quantified by plaque assay (pfu/ml) after 8 h, 12 h, and 24 h.p.i. The graphs show mean ± SEM 
(triplicates per condition, three independent experiments). Significant differences between treated and control 
cells are marked with * (p < 0.05).
www.nature.com/scientificreports/
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We then studied the role of actin on PIXV infection, using drugs that alter the structural integrity and dynam-
ics of MFs. The treatment with Cyt D increased the virus yields in the extracellular medium. Furthermore, the 
actin-stabilizing agent, Jpk, had no effect over virus yield. These results indicate that the disruption of the actin 
cytoskeleton could facilitate the entry of viral particles into the host cell, probably promoting endocytosis and 
thus increasing the entry of viral particles into the endosomal system. It is well known that actin assembly plays 
an essential role in several processes leading to endocytosis, including the internalization of clathrin-coated vesi-
cles21. Since alphaviruses enter the target cells by clathrin-mediated endocytosis22, 23, it is reasonable to think that 
the cortical actin barrier underlying the plasma membrane might need to be dissolved or removed, as proposed 
by Qualmann et al.24. Regarding the effect of MFs-binding agents on virus yields, it has been reported that Cyt 
D does not reduce SINV yields in infected cells25. However, the exposure to the same drug significantly reduces 
the percentage of cells infected with CHIKV, suggesting that the integrity of actin fibers is required at least for the 
internalization of this virus26.
In summary, our findings demonstrate an increase in extracellular viral titters after the disorganization of 
actin MFs with Cyt D. This particular observation, together with the remarkable reorganization of subcortical 
actin, raises new questions about possible interactions between PIXV and MFs, as well as particular require-
ments of cytoskeleton dynamics during viral entry. More importantly, we observed that either the inhibition of 
polymerization of MTs with NZ or their stabilization with TX interfere with PIXV infection cycle in host cells. 
Figure 5. Effect of microtubule and microfilament disrupting agents on virus production at the different phases 
of the virus replication cycle. Cells were infected with PIXV and treated during the first 4 h.p.i. (eclipse phase A, 
C and E), or 4 to 12 h.p.i (exponential phase B, D and F) with NZ (A,B), TX (C,D) and Cyt D (E,F). Infectious 
particles in cell culture supernatants were quantified by plaque assay (pfu/ml) at 8 and 12 h.p.i. The graphs show 
mean ± SEM (triplicates per condition, three independent experiments). Significant differences between treated 
and control cells are marked with * (p < 0.05).
www.nature.com/scientificreports/
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This indicates that specific interactions with these elements are necessary for the normal development of viral 
replication. Considering that these drugs are already used in human chemotherapy27, it would be interesting to 
study their potential antiviral activity.
Although the precise mechanisms of interaction between PIXV and the host cell cytoskeletal elements remain 
to be defined, knowing the different interactions between this alphavirus and cytoskeletal components is crucial, 
not only for understanding the basis of early pathogenesis, but also for shedding light on possible new antiviral 
treatments.
Experimental Procedures
Cells and virus. Vero cells (Vero 76, ATCC CRL 1587) were grown in Dulbecco’s modified Eagle’s medium 
(DMEM) (GIBCO, USA) with 10% fetal calf serum (FCS), Gentamicin (50 µg/ml), at 37 °C, 5% CO2 and 98% 
humidity. The PIXV strain BeAr 35645, isolated from Anopheles nimbuspor in Brazil4, was propagated in Vero 
cells and stocks were stored at 7 × 106 plaque-forming units (PFU/ml). Virus yields (PFU/ml) were determined 
by a standard plaque assay28, 29. Briefly, infected Vero cell monolayers were overlaid with 1.5% ultra pure agarose 
(Gibco BRL) in 4% DMEM 2x. Two days later, the cells were fixed with 10% formaldehyde in water and the over-
laid medium was removed. Then, the monolayers were stained with 1% crystal violet in water and the plaques 
were counted. Infectivity titers were expressed as PFU/ml. All the experiments with PIXV were performed in a 
laminar flow hood under biosafety level 2 conditions.
Synchronized infection. Vero cells were plated at 1 × 105 cells/well in 100 μl of complete medium and incu-
bated at 37 °C, 5% CO2 and 98% humidity. Confluent monolayers of Vero cells were infected at different multiplic-
ity of infection (MOI) 0.1, 1 or 10. Virus adsorption was performed at 4 °C per 1 h. After this first incubation, the 
inoculum was removed and monolayers were washed with phosphate-buffered saline (PBS) at 4 °C to eliminate 
any free virus particle and DMEM with 1% FCS was added before incubating at 37 °C, 5% CO2 and 98% humidity 
for 8, 12 or 24 h, depending on the experiment. Cytopathic effect was evaluated by direct visualization by phase 
contrast microscopy at low magnification, using an Olympus IX81 microscope.
Time course of infection. After identifying a MOI of 0.1 as the optimal MOI to obtain cytopathic effects 
without compromising the integrity of the cell monolayer, Vero cells were infected at this MOI as described in 
the above section. Supernatants were harvested at 2, 4, 6, 8, 12, 18, 24 and 48 h post infection (h.p.i.) and tittered 
by plaque assay.
IF staining. To visualize the actin and microtubule network, cell monolayers were grown at 60% conflu-
ence on glass coverslips, washed three times with PBS, fixed with 4% paraformaldehyde/4,1% sucrose (Riedel-de 
Haën, Sigma-Aldrich Laborchemikalien GmbH, Seelze, Germany) for 20 min at room temperature (RT) and then 
washed with PBS. The cells were then permeabilized with 0.2% TritonTM X-100 (Sigma-Aldrich, St. Louis, MO) 
in PBS for 5 min at RT and incubated with 5% bovine serum albumin (BSA, Sigma-Aldrich, St. Louis, MO) for 
1 h at RT. The cells were incubated with the primary antibodies (mouse anti-α-tubulin – DM1A, Sigma-Aldrich, 
St. Louis, MO) diluted 1/1000 in 1% BSA/PBS solution over night at 4 °C. Then, monolayers were washed three 
times with PBS, and incubated with the secondary antibodies (goat anti-mouse, Alexa Fluor 488 (Thermo Fisher 
Scientific Inc., Waltham, Massachusetts, USA) for 2 h at RT. To visualize the actin filaments, the fixed and perme-
abilized cell monolayers were labeled with Phalloidin-Tetramethyl rhodamine B (Sigma-Aldrich, St. Louis, MO) 
for 1 h at RT. In order to evidence viral structural proteins, the same procedure was performed using an anti-PIXV 
primary polyclonal IgG antibody generated in mice, in our laboratory. Cells were visualized using a conventional 
inverted epi-fluorescence microscope (Olympus IX81, Olympus Corporation, Shinjuku, Tokyo). Images were 
processed using Adobe Photoshop CS6 (Version: 13.0).
Western blot. Changes in the levels of intracellular viral proteins sequential expression were analyzed by 
western blot as previously described30. Briefly, infected Vero cells were lysed in RIPA buffer (1% Triton X-100, 
0.5% deoxycholate, 0.1% SDS, 1 mM CaCl2, 0.5 mM MgCl2, and protease inhibitor cocktail) after 4, 8, 12, and 
24 h.p.i., the insoluble debris was removed by centrifugation at 16,000 g. Forty μg of whole-cell extracts were 
resolved on 12% SDS-PAGE and transferred to polyvinylidene difluoride membranes (PVDF, Thermo Scientific, 
IL, USA). The membranes were incubated with anti-PIXV mouse primary polyclonal antibody (1/1000) overnight 
at 4 °C and then with a secondary horseradish peroxidase-conjugated anti-mouse antibody (1/800) (Promega 
Corporation, Madison, WI) for 1 h at RT. Anti-GAPDH antibody was used as a loading control (Sigma-Aldrich, 
St. Louis, MO, 1:5000). Blots were developed using a chemiluminiscence detection kit (ECL; GE Amersham) for 
the visualization of reactive bands.
Pharmacological treatment. Cellular metabolic activity was evaluated after treatment with increasing 
concentrations of NZ (1–300 μM), TX (2–500 μM), Cyt D (0.30–80 μM) (Sigma-Aldrich, St. Louis, MO), and 
Jpk (0.03–10 μM) (Calbiochem, St. Diego, CA). Cellular metabolic activity was determined after 24 h of treat-
ment using a colorimetric assay based on the reduction of tetrazolium salt (2,3-bis[2-methyloxy-4-nitro-5-su
lfophenyl]-2H-tetrazolium-5-carboxanilide [XTT])31. A concentration of each drug that results in cellular meta-
bolic activity higher than 90% was chosen for subsequent experiments (Table 1). Synchronized virus adsorption 
was performed at 4 °C as described above and monolayers were exposed to the different drugs during 24 h (com-
plete cycle; NZ, TX, Cyt D, and Jpk) or during each viral cycle phase (eclipse and exponential growth phase up 
to 12 h; for NZ, TX and Cyt D). After the treatment period, the culture supernatants were harvested at 8, 12, and 
24 h.p.i., and extracellular infective PIXV titers were determined by standard Vero cell plaque assay and expressed 
as plaque forming units per milliliter (PFU/mL).
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Statistical analysis. All data sets passed the normality test (D´Agostino –Pearson normality test). Data are 
representative of at least three independent experiments and values are given as mean ± standard deviation (SD). 
Statistical analysis was carried out using one-way ANOVA test, followed by post-hoc Fisher´s analysis to enable 
specific group comparison. A p < 0.05 was considered statistically significant. All tests were performed using 
Statistic 7 (Statsoft, Inc.; OK, USA).
Data Availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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